Skip to content

Clinical trials

Phase 2 COVID-19 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2 Country / region: United States Clear all

337 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20183
20192
2020189
202192
202217
202318
20248
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed175
Terminated97
Withdrawn27
Unknown status14
Active, not recruiting13
Recruiting7
Enrolling by invitation2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)11
NYU Langone Health7
Pfizer7
Sorrento Therapeutics, Inc.7
Washington University School of Medicine7
Johns Hopkins University6
Stanford University6
Massachusetts General Hospital5
ModernaTX, Inc.5
Memorial Sloan Kettering Cancer Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19337
Coronavirus Infections80
Respiratory Distress Syndrome23
Severe Acute Respiratory Syndrome22
Pneumonia21
Post-Acute COVID-19 Syndrome13
Cytokine Release Syndrome11
Virus Diseases11
Respiratory Insufficiency9
Anosmia7

Trials

Showing 1 to 25 of 337. Each trial links to its page on Pharma Observatory.

237 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.